Gene therapy is entering a new era. Recent technological breakthroughs are transforming the field, unlocking new possibilities for clinical applications and offering hope for patients with previously untreatable genetic diseases. In this session, discover how innovative recombinant adeno-associated virus (rAAV) manufacturing technologies are advancing gene therapies by enabling more precise, effective, and safer gene delivery. Learn why success starts with the best cell lines—featuring fully characterized genome organizations, higher yields of fully functional viral particles, and improved scalability. Join us to explore how our next-generation tools are setting a new standard and revolutionizing the future of gene therapy.